Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Current Leases (2019 - 2025)

aTYR PHARMA (ATYR) has disclosed Current Leases for 7 consecutive years, with $836000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Leases rose 54.53% year-over-year to $836000.0, compared with a TTM value of $836000.0 through Dec 2025, up 54.53%, and an annual FY2025 reading of $836000.0, up 54.53% over the prior year.
  • Current Leases was $836000.0 for Q4 2025 at aTYR PHARMA, up from $799000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $1.0 million in Q1 2022 and bottomed at $70000.0 in Q2 2022.
  • Average Current Leases over 5 years is $679052.6, with a median of $683000.0 recorded in 2024.
  • The sharpest move saw Current Leases tumbled 92.38% in 2022, then soared 532.86% in 2023.
  • Year by year, Current Leases stood at $949000.0 in 2021, then plummeted by 33.61% to $630000.0 in 2022, then skyrocketed by 31.9% to $831000.0 in 2023, then plummeted by 34.9% to $541000.0 in 2024, then soared by 54.53% to $836000.0 in 2025.
  • Business Quant data shows Current Leases for ATYR at $836000.0 in Q4 2025, $799000.0 in Q3 2025, and $562000.0 in Q2 2025.